Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Caida de cabello E
Microcirculación cerebral E
Rinovirus V
Plasmodium vivax malarie P
Sinusistis V
Sthahylococus epidermis B
Estreptococo fragilis B
Escabiasis P
Herpes II V
Bacilo pertusis B
Disfunción de la tiroides DG
Estreptococo faecalis B
Blastocystis hominis P
Disfunc de las Suprrarenales DG
Micobacterium leprae B
Staphilococus aureus C (+) B
Aftosavirus V
Disfunción glandular/Alvaro DG
Estreptococo A B
Candida Albicans H
Disfunción Colon DG
Brucella B
Reservorio de bacterias RB
Estreptococo C B
Inmunocompetencia/Angeles E
Varicela V
Estreptococo C B
Coronavirus V
Bibliografía:
https://es.wikipedia.org/wiki/Esclerodermia
Fett, N (2013 Jul-Aug). «Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies».
Clin Dermatol 31 (4): 432-7.
Kreuter, A (2012 Mar-Apr). «Localized scleroderma». Dermatol Ther 25 (2): 135-47.
Ariel D. Teitel, MD, MBA, Clinical Associate Professor of Medicine, NYU Langone Medical Center. Review provided by VeriMed
Healthcare Network. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, Bethanne
Black, Stephanie Slon, and Nissi Wang. Traducción y localización realizada por: DrTango, Inc. «Esclerodermia» (en spa).
«Morphoea». DermNet NZ.
Ngan, Vanessa. «Systemic sclerosis». DermNet NZ (en eng).
Scleroderma Society (Revised October 2008). «Understanding and managing scleroderma». Archivado desde el original el 2 de
junio de 2014.
Hinchcliff, M; Varga, J (2008 Oct15). «Systemic sclerosis/scleroderma: a treatable multisystem disease». Am Fam Physician 78 (8):
961-8.
Kerr, AC; Ferguson, J; Attili, SK; et al. (2012 Apr). «Ultraviolet A1 phototherapy: a British Photodermatology Group workshop
report». Clin Exp Dermatol 37 (3): 219-26.
Cantisani, C; Miraglia, E; Richetta, AG; et al. (2013 Jan). «Generalized morphea successfully treated with tacrolimus 0.1%
ointment». J Drugs Dermatol 12 (1): 14-5.
Manno, R; Boin, F (2010 Nov). «Immunotherapy of systemic sclerosis». Immunotherapy 2 (6): 863-78.
Goundry, B; Bell, L; Langtree, M; et al. (2012 Feb). «Diagnosis and management of Raynaud's phenomenon». BMJ 7: 344:e289.
Kowal-Bielecka, O; Landewe, R; Avouac, J; et al. (2009 May). «EULAR recommendations for the treatment of systemic sclerosis:
a report from the EULAR Scleroderma Trials and Research group (EUSTAR)». Ann Rheum Dis 68 (5): 620-8.
Denton, CP; Lapadula, G; Mouthon, L; et al. (2009 Jun). Renal complications and scleroderma renal crisis. Rheumatology (Oxford)
48 (Suppl 3).
Desai, CS; Lee, DC; Shah, SJ (2011 Nov). «Systemic sclerosis and the heart: current diagnosis and management». Curr Opin
Rheumatol 23 (6): 545-54.